NMR studies of [U-13C]cyclosporin A bound to human cyclophilin B  by Neri, Placido et al.
Volume 290, number 1,2, 195-199 FEBS 10200 
8 i991 Federation or” European Biochemicai Societies 00145793191153.50 
,IDONIS 001457939100911D 
September 199 1 
Placido Neri’, Gerd Gemmecker’, Eynne D. Zydowsky’, Christopher T. Walsh’ and Stephen W. Fesik’ 
‘Pharmaceutical Discovery Division, Abbott Laboratories, Abbott Park, IL 60064. USA and ‘Department of Biological 
Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115. WSA 
Received 19 July 1991 
NMR data (‘I3 and I36 chemical shifts, NOES) on [[U-“C]cyclosporin A bound to cyclophilin B were compared to previously published data on 
the ~-‘3C]CsNCyPA complex [Fesik et al., (1991) Biochemistry 30,6574-.6583]. Despite only 64% sequence identity between CyPA and CyPB, 
the conformation and active site environment of CsA when bound to CyPA and CyPB are nearly identical as judged by the similarity of the NMR 
data. 
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1, INTRODUCTION 
The cyclophilins (CyPs) are a family of proteins 
found in mammalian, fungal, and procaryotic orga- 
nisms [l-12] that catalyze &-tram peptidyl-prolyl iso- 
merization [13,14]. Cyclophilin from human T cells 
(CyPA) as well as other cyclophilins, bind to and are 
inhibited by the immunosuppressive drug cyclosporin A 
(CsA) (Fig. 1) [l-12]. For most CsA analogs, the rela- 
tive affinity for cyclophilin correlates with their immu- 
nosuppressive activity, suggesting that the immunosup- 
pressive effects of CsA involve bin.ding to cyclophilin 
[ 1,15-l 81. However, for a few CsA analogs cyclophilin 
binding does not correlate with immunosuppressive ac- 
tivity (e.g. [MeAla and [MeBm$‘CsA), questioning 
the role of cyclophilin in CsA-mediated immunosup- 
pression [17,18]. 
One possible explanation for these apparent discre- 
panties is that CsA exerts its immunosuppressive ffects 
by binding to a different, yet structurally related, cy- 
clophilin. Recently, a second human cyclophilin, cy- 
clophilin B (CyPB) [19], has been cloned and was found 
to be 64% identical to human CyPA. Unlike CyPA 
which is cytosolic, CyPB contains a hydrophobic N- 
terminal signal sequence which is removed upon expres- 
sion in i3 coli [19]. Recent localization studies have 
shown CyPB to be located in the endoplasmic reticu- 
lum, Golgi and vesicles in the cytoplasm (Jin, et al., 
unpublished). CyPB possesses cis-trans peptidyl-prolyl 
isomerase (PPIase) activity which is inhibited by CsA 
[19] at three-foid higher concentration than CyPA. 
Thus, CyPB may also play an significant role in T-cell 
activation. 
In this report we describe NMR studies on the bind- 
ing of [U-‘3C]CsA to human cyclophilin B and compare 
the results to previously described NMR studies on the 
[U-‘3C]CsA/CyPA complex [Xl. 
2. MATERIALS AND METHODS 
2. I. Materials 
[U-‘“C]CsA was isolated from Beauveria nivcu ATCC 34921 (Ameri- 
can Type Culture Collection; Rockville, MD) culture containing [U- 
‘“C]Celtone medium (Ms,rt,ek Corp., Columbia, MD) [ZO]. Recom- 
binant human cyclophilin A was prepared as recently described [21]. 
A genetically truncated human cyclophilin 0 (residues 24-208) was 
overexpressed in E. m/i and purified to homogenity as previously 
described [ 191. 
2.2. NMR experiments 
The cyclophilin samples (A and E) were exchanged into a DzO 
solution (pH 6.5) containing phosphate buffer (SO mM), NaCI (100 
mM), and dithiothreitol(5 mM) and concentrated to -1.0 mM with a 
centricon YM-IO (Amicon). 
The [U-‘“C]CsA/cyclophilin (A and 8) complexes were prepared by 
gently shaking a suspension of -1.5 mol equivalents of [U-‘“C]CsA in 
a II20 solution of cyclophilin at 6°C for 12 h under argon. The excess 
CsA was removed bv centrifuaation. 
Abbreviations: CyP, cyclophilin (A or B); CsA, cyclosporin A; NOE, 
nuclear Overhauser effect; HSQC, heteronuclear single quantum cor- 
relation; HMQC-NOESY, hcteronuclear multiple quantum correla- 
tion-nuclear Overhauser effect spectroscopy. 
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All NMR spectra were acquired on a Bruker AMXSOO NMR spec- 
trometer at 20°C. The spectra were processed using in-house written 
software on Silicon Graphics computers or the Bruker UXNMR 
software package on a Bruker X32. 
The heteronuclear single quantum correlation (HSBC) spectra [22] 
were acquired using 2048 complex points in Fz and 5 I2 complex points 
in F,, with 96 scans. The sweep width was 7812.5 Hz in FZ and 7462.7 
Hz in F,. 
The 3D HMQC-NOESY experiments [23] were acquired as 48(t,) 
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Fig. I. (a) Structure of CsA. (b) Conformation of Csh when bound 
to CyPA [20]. 
x 128 (tz) x 2048(tJ complex points using a mixing time of 50 ms and 
spectral widths of 7462.7 Hz in w, and 7812.5 Wz in w2 and wJ. 32 
acquisitions were collected per 1, experiment for a total experimental 
time of approximately 6 days. 
3. RESULTS 
As a first step in probing for any structural differen- 
ces between the [IJ-‘3C]CsA/CyPA and [U-‘3C]CsA/ 
CyPB complexes, we compared their proton NMB 
spectra. As expected for two proteins with 64% se- 
quence identity, the proton NMR spectra of the two 
CsA/CyP complexes, which mainly consisted of protein 
signals (data not shown), were markedly different. In 
contrast, as shown in the two-dimensional heteronu- 
clear single quantum correlation (HSQC) spectra [22] of 
[IJ-‘3C]CsA bound to CyPA (Fig. 2a) and CyPB (Fig. 
2b), the ‘H and 13C chemical shifts of [U-‘?]CsA when 
bound to either protein are nearly identical. The assign- 
ment of the signals was easily deduced by a direct com- 
parison of the two HSQC spectra and confirmed in the 
3D HMQC-NQESY spectra [20]. The observed chemi- 
cal shift differences in ppm (&,,,-6,,,,,) were: 1Ha 
(-0.04), 5H” (-O-07), 8H” (-0.05) 9H” (-O.lO), 9Hb 
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(-0.16, -0.06), 9@ (-0.3) 1lNCm (+0.05), IIH” 
(-0.04) 11C” (40.4). All other signals resonate at the 
same frequencies within the limits of experimental error 
[20]. In Fig. 2 some signals are invisible at the level 
chosen for the plot, but can be observed with lower 
contouring. The residual protein cross-peaks that are 
detected in the HSQC spectra (indicated by P in Fig. 2) 
are different in the two cases, reflecting the sequence 
differences in the two proteins. 
In Fig. 3 three-dimensional HMQC-NQESY spectra 
[23] are compared for [U-‘jC]CsA bound to CyPA (top 
of each panel a-e) and CyPB (bottom of each panel 
a-e). ‘l-l, ‘l-l planes were extracted at the same 13C fre- 
quencies in the two data sets. As shown by the compa- 
rison of the spectra obtained for the two complexes, 
similar NOES, with the same relative intensities, were 
observed. Some weak NOES present in the CypA data- 
set could not be observed in the 3D NOE spectrum of 
CypB due to a lower signal-to-noise ratio. 
In Fig. lb the conformation of GSA when bound to 
CyPA is shown that had been previously determined 
from 3D NOE data [20]. The bound conformation of 
CsA [20,24,25] was found to be very different from the 
previously determined NMR-derived or X-ray crystal 
structure of cyclosporin A determined in the absence of 
cyclophilin [26]. When bound to cyclophilin, CsA 
adopts a tram 9,lO peptide bond [24] in contrast to the 
9,lO cis peptide bond found in free GSA [26]. In addi- 
tion, the backbone conformation and the orientations 
of some of the side chains greatly differ between the 
structures [20,25]. 
It is important to note key long range NOES impor- 
tant in defining the overall backbone conformation of 
CsA when bound to CyPA (Fig. 1 b) [20] were also 
observed in the 3D NOE spectrum of the CsA/CyPB 
complex. Some of these include NOES from 6NCI-I, to 
5H”, INCH, and 10NCH3 (Fig. 3a) and NOES from 
5Hy’ to INCH3 and 3NCH, (Fig. 3b). NOES between 
CsA protons indicative of a particular side chain con- 
formation were also found to be the same in the CsA/ 
CyPA [20] and CsA/CyPB complexes. For example, the 
o- proton of MeBmt’ is close to its own/3 and GCH3 side 
chain protons (Fig. 3~) and MeEeu6(H”‘) is in close 
proximity to MeLe$(H”) (Fig. 3b) in both complexes. 
NOES between CsA and the protein were also found to 
be similar in the two complexes (e.g. Fig. 3d). An excep- 
tion is shown in Fig. 3e in which an additional NOE 
between MeVal” (NCH3) and an aromatic proton of 
the protein (arrow) was observed in the [U-‘“C]CsA/ 
CyPB complex. Another difference is shown in Fig, 2d 
in which a small change in chemical shift of one of the 
NQE peaks involving the protein and MeVal”(Hy2) 
was observed, suggesting the CyP binding pocket in the 
vicinity of the MeVal” CsA residue is slightly different 
in the two complexes. This is supported by the differen- 
ces in chemical shift of the 1 lNCH3, 11 H”, and 11C” 
signals of CsA when bound to CyPA or CyPB. 
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Fig. 2. Contour plots of the HSQC spectra of [U-‘3C]CsA bound to (a) CyPA and (b) CyPB. The ‘x’ refers to experimental rtifacts. *The 
MeBmt’(H() signals were not fully “C-decoupled at the power level employed. 
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Fig. 3. Comparison of corresponding cross-sections (w,, vertical axis; ml, horizontal axis) from 3D-HMQC-NOES!’ spectra of [U-“C]CsA bound 
to CyPA (top of each panel) and CyPB (bottom of each panel), acquired with a mixing time of 50 ms. In both spectra the planes were taken at 
the same 13C chemical shifts (0,) of (a) 31.8, (b) 19.4, (c) 58.1, (d) 16.3, (e) 33.2 ppm. The skewed solid lines indicate the diagonal peaks on the 
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‘8%‘I-I NOESY planes. 
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4. DISCUSSIQN 
Despite only 64% sequence identity between CyPA 
and CyPB, the chemical shift and NOE data suggest 
that the conformation and active site environment of 
GSA when bound to CyPA and CyPB is very similar. 
Even for CsA residues (e.g. residue 1 and 6) in which 
structural changes produced analogs in which cyclophi- 
lin binding and immunosuppressive activity did not cor- 
relate [ 17,18], the chemical shifts and NOES involving 
these residues were found to be identical. These results 
suggest hat the apparent discrepancies in CyP binding 
and immunosuppressive activity displayed by some 
CsA analogs cannot simply be explained by invoking 
CyPB as the biologically relevant cyclophilin. Indeed, 
the relative amounts of PPIase inhibition for CyPA and 
CyPB with [MeAla’] and [MeBm?t’]CsA show little dif- 
ference with the two cyclophilin lsoforms (Anderson et 
al., unpublished). It may be that the complexes of cy 
clophilins (A and/or I3) with cyclosporin or CsA analogs 
may exhibit differential affinities with partner proteins 
immediately downstream in the signal transduction 
cascade and that is the relevant immunosuppressive 
readout. 
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